Skip to content

Demonstration study on early recognition, intervention and comprehensive service technology of traditional Chinese medicine for chronic obstructive pulmonary disease

Demonstration study on early recognition, intervention and comprehensive service technology of traditional Chinese medicine for chronic obstructive pulmonary disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048945
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Gold Standard:Clinical outcome
model&#32
system

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medicine University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for the early diagnosis model of COPD: (1) Patients who meet the diagnostic criteria of chronic obstructive pulmonary disease, are in stable stage or have more than one of the high-risk factors of chronic obstructive pulmonary disease; (2) Aged over 40 years; (3) Informed consenters: voluntarily tested and signed the informed consent form, and the informed consent process met the ethical requirements. 2. Inclusion criteria for COPD early intervention cohort study: (1) Post-diastolic pulmonary ventilation function FEV1/FVC is less than 0.7 and FEV1 accounts for the predicted value greater than 0.5; (2) Aged over 40 years; (3) Informed consenters: voluntarily tested and signed the informed consent form, and the informed consent process met the ethical requirements.

Exclusion criteria

Exclusion criteria: 1. Combined with serious primary diseases of the heart, liver, kidney, brain, hematopoietic system, etc.; 2. Subjects with limited giant bullae, pneumothorax, and extremely weak or physically disabled subjects; 3. Pregnant or lactating subjects; 4. Mental subjects; 5. Those who are unwilling to accept research measures, or who cannot cooperate for other reasons; 6. Subjects currently participating in other drug clinical trials or intervention studies.

Design outcomes

Primary

MeasureTime frame
acute exerbation frequency;life quality rating;breathing difficult index;pulmonary function;

Countries

China

Contacts

Public ContactWang Zhen

The First Affiliated Hospital of Zhejiang Chinese Medicine University

wangzhen610@sina.cn+86 13605801386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026